Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining -0.39% today. In the last week its performance is 5.81%, and 6.74% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 47, so today’s gain of -0.39% is a significant step towards its target price. The GAP today is therefore -1.27%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 104934.18, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 8.90%.
At the current price of 43.17, it has a dividend yield of 5.14%, and its target price is 47. This is with a profit margin of 2.50%, and total debt/equity of 6.05. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 129.25, as well as a forward P/E of 16.51.
With a current EPS of 0.33, and a forecasted EPS growth for next year at 12.87%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 0.60%.
Performance for the year is 9.76%. Since its IPO date on 07/09/1986, the total performance to date is 11.85%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 3168838, while its average volume is 3561.14. Whilst the total gain today was -0.39%, it did have a day high of -0.39%.
Volatility for this week has been at 1.69%, and 1.49% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 22.91%, while the 52-week-high has reached -0.39%.
Looking at its return of investments, which is 41.40%, and its return on assets is 1.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 7.50%. With a sales growth of 10.80% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 5.61, and has a current ratio of 1.1 and 0.8 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 215.42, and the P/S is 3.21, along with a P/B of 28.03. Meanwhile it has a p/cash of 17.58.